eli lilly tirzepatide self pay sold $176 million of the weight loss drug Zepbound in just 4 weeks Lilly Launches Additional Zepbound Vial

While the science is still catching up, Byrne suspects that middle-aged women may be particularly vulnerable to Ozempic face because of hormonal shifts and a natural decline in collagen production during the menopause transition

This Site may provide access to additional information that may be of use to physicians and other health care providers

While the inflammation-reducing and fibrosis-attenuating effects of glucagon agonism are less well-characterized, the reductions in hepatic inflammation parameters and fibrosis observed in preclinical models likely reflect secondary effects consequent to improved steatosis, rather than direct anti-inflammatory actions [21]

Tirzepatide's half-life is 5 days, so it's designed for once-weekly dosing